Shyam Karki

2.2k total citations · 2 hit papers
29 papers, 1.9k citations indexed

About

Shyam Karki is a scholar working on Pharmaceutical Science, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Shyam Karki has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 10 papers in Molecular Biology and 10 papers in Materials Chemistry. Recurrent topics in Shyam Karki's work include Drug Solubulity and Delivery Systems (13 papers), Crystallization and Solubility Studies (10 papers) and Crystallography and molecular interactions (8 papers). Shyam Karki is often cited by papers focused on Drug Solubulity and Delivery Systems (13 papers), Crystallization and Solubility Studies (10 papers) and Crystallography and molecular interactions (8 papers). Shyam Karki collaborates with scholars based in United States, United Kingdom and Switzerland. Shyam Karki's co-authors include William Jones, Tomislav Friščić, L. Fábián, Graeme M. Day, Peter R. Laity, W. D. Samuel Motherwell, Sumit Kumar, Yuchuan Gong, Biplob Mitra and Anjali Agrawal and has published in prestigious journals such as Advanced Materials, Chemical Communications and International Journal of Pharmaceutics.

In The Last Decade

Shyam Karki

29 papers receiving 1.8k citations

Hit Papers

Improving Mechanical Properties of Crystalline Solids by ... 2009 2026 2014 2020 2009 2021 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Improving Mechanical Properties of Crystalline Solids by Cocrystal Formation: New Compressible Forms of Paracetamol
    2009 469 citations Shyam Karki, Tomislav Friščić et al. profile →
  2. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies
    2021 351 citations Sonal V. Bhujbal, Biplob Mitra et al. Acta Pharmaceutica Sinica B profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shyam Karki United States 15 1.1k 1.1k 441 292 265 29 1.9k
Amjad Alhalaweh Sweden 24 1.4k 1.2× 940 0.9× 676 1.5× 354 1.2× 106 0.4× 35 2.2k
Héctor R. Guzmán United States 9 1.2k 1.1× 811 0.8× 441 1.0× 229 0.8× 238 0.9× 12 1.8k
Kuthuru Suresh India 25 1.0k 0.9× 652 0.6× 291 0.7× 237 0.8× 591 2.2× 36 1.8k
Palash Sanphui India 23 1.4k 1.3× 1.5k 1.4× 328 0.7× 548 1.9× 490 1.8× 50 2.4k
Suryanarayan Cherukuvada India 21 969 0.9× 964 0.9× 192 0.4× 343 1.2× 303 1.1× 34 1.4k
Magali B. Hickey United States 17 904 0.8× 913 0.9× 221 0.5× 277 0.9× 271 1.0× 29 1.3k
Julius F. Remenar United States 18 1.4k 1.2× 1.0k 1.0× 558 1.3× 741 2.5× 424 1.6× 26 2.4k
Artem O. Surov Russia 25 940 0.8× 864 0.8× 188 0.4× 463 1.6× 239 0.9× 64 1.4k
Geetha Bolla India 22 1.3k 1.1× 1.3k 1.2× 150 0.3× 441 1.5× 498 1.9× 37 1.9k
Ranjit Thakuria India 26 1.5k 1.3× 1.4k 1.3× 262 0.6× 748 2.6× 462 1.7× 79 2.5k

Countries citing papers authored by Shyam Karki

Since Specialization
Citations

This map shows the geographic impact of Shyam Karki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shyam Karki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shyam Karki more than expected).

Fields of papers citing papers by Shyam Karki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shyam Karki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shyam Karki. The network helps show where Shyam Karki may publish in the future.

Co-authorship network of co-authors of Shyam Karki

This figure shows the co-authorship network connecting the top 25 collaborators of Shyam Karki. A scholar is included among the top collaborators of Shyam Karki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shyam Karki. Shyam Karki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhujbal, Sonal V., Biplob Mitra, Yuchuan Gong, et al.. (2021). Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharmaceutica Sinica B. 11(8). 2505–2536. 351 indexed citations breakdown →
2.
Gong, Yuchuan, Anjali Agrawal, Shyam Karki, et al.. (2021). A Novel Use of Nanocrystalline Suspensions to Develop Sub-Microgram Dose Micro-Tablets. Journal of Pharmaceutical Sciences. 110(9). 3276–3288. 6 indexed citations
3.
Tabriz, Atabak Ghanizadeh, Uttom Nandi, Andrew P. Hurt, et al.. (2020). 3D printed bilayer tablet with dual controlled drug release for tuberculosis treatment. International Journal of Pharmaceutics. 593. 120147–120147. 70 indexed citations
4.
Gong, Yuchuan, et al.. (2020). Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets. International Journal of Pharmaceutics. 577. 119026–119026. 10 indexed citations
5.
Li, Jianmin, et al.. (2020). Development of low dose micro-tablets by high shear wet granulation process. International Journal of Pharmaceutics. 587. 119571–119571. 16 indexed citations
6.
Karki, Shyam, et al.. (2019). Downstream processing of irbesartan nanocrystalline suspension and mini-tablet development – Part II. International Journal of Pharmaceutics. 568. 118509–118509. 14 indexed citations
7.
Karki, Shyam, et al.. (2019). Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders – Part I. International Journal of Pharmaceutics. 568. 118189–118189. 33 indexed citations
8.
Osei-Yeboah, Frederick, et al.. (2017). Engineered particles demonstrate improved flow properties at elevated drug loadings for direct compression manufacturing. International Journal of Pharmaceutics. 523(1). 133–141. 15 indexed citations
9.
Box, Karl, John Comer, Robert Taylor, et al.. (2015). Small-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration. AAPS PharmSciTech. 17(2). 245–251. 21 indexed citations
10.
Karki, Shyam, et al.. (2013). Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer. International Journal of Pharmaceutics. 453(2). 380–388. 45 indexed citations
11.
Dong, Jinquan, et al.. (2012). Oxidative degradation studies of an oxazolidinone-derived antibacterial agent, RWJ416457, in aqueous solutions. Drug Development and Industrial Pharmacy. 38(11). 1289–1297. 3 indexed citations
12.
Sato, Yuichi, et al.. (2010). Parenteral formulation and thermal degradation pathways of a potent rebeccamycin based indolocarbazole topoisomerase I inhibitor. International Journal of Pharmaceutics. 390(2). 128–133. 1 indexed citations
13.
Cruz‐Cabeza, Aurora J., Shyam Karki, L. Fábián, et al.. (2010). Predicting stoichiometry and structure of solvates. Chemical Communications. 46(13). 2224–2224. 73 indexed citations
14.
Wu, Wenju, et al.. (2009). The mechanism of the formation of enantiotropic polymorphs of carisbamate in solution crystallization. Journal of Crystal Growth. 311(13). 3435–3444. 6 indexed citations
15.
Breslin, David T., Yuichi Sato, & Shyam Karki. (2009). Mechanism of hydrolysis of a novel indolocarbazole topoisomerase I inhibitor. European Journal of Pharmaceutical Sciences. 39(5). 291–297. 3 indexed citations
16.
Karki, Shyam, L. Fábián, Tomislav Friščić, & William Jones. (2007). Powder X-ray Diffraction as an Emerging Method to Structurally Characterize Organic Solids. Organic Letters. 9(16). 3133–3136. 87 indexed citations
17.
18.
19.
20.
Karki, Shyam & Dražen Ostović. (2003). Assessing aggregation of peptide conjugate of doxorubicin using quasi-elastic light scattering and 600 MHz NMR. International Journal of Pharmaceutics. 271(1-2). 181–187. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amjad Alhalaweh Breakdown of academic impact, for papers by Héctor R. Guzmán Breakdown of academic impact, for papers by Kuthuru Suresh Breakdown of academic impact, for papers by Palash Sanphui Breakdown of academic impact, for papers by Suryanarayan Cherukuvada Breakdown of academic impact, for papers by Magali B. Hickey Breakdown of academic impact, for papers by Julius F. Remenar Breakdown of academic impact, for papers by Artem O. Surov Breakdown of academic impact, for papers by Geetha Bolla Breakdown of academic impact, for papers by Ranjit Thakuria
Rankless by CCL
2026